Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection.

Crawford, Tonya; Huesgen, Emily; Danziger, Larry

Crawford, Tonya; Huesgen, Emily; Danziger, Larry.

Affiliation

Crawford T; Center for Advanced Design, Research, and Exploration, University of Illinois at Chicago, Chicago, USA.

Am J Health Syst Pharm ; 69(11): 933-43, 2012 Jun 01.

Article in En | MEDLINE | ID: mdl-22610025

Subject(s)

Aminoglycosides/therapeutic use; Anti-Bacterial Agents/therapeutic use; Clostridium Infections/drug therapy; Aminoglycosides/administration & dosage; Aminoglycosides/adverse effects; Anti-Bacterial Agents/administration & dosage; Anti-Bacterial Agents/adverse effects; Clostridioides difficile/drug effects; Clostridium Infections/microbiology; Fidaxomicin; Humans; Microbial Sensitivity Tests; Severity of Illness Index; Vancomycin/adverse effects; Vancomycin/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Clostridium Infections / Aminoglycosides / Anti-Bacterial Agents Type of study: Prognostic_studies Language: En Journal: Am J Health Syst Pharm Year: 2012 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google